filmov
tv
Implications of Newly Revised Alzheimer Disease Diagnostic and Staging Criteria
Показать описание
Clifford R. Jack Jr., MD, a neuroradiologist at Mayo Clinic, talked about revised guidelines for diagnosing and staging Alzheimer disease, which reflect recent scientific advancements and integrate cutting-edge biomarkers and diagnostic tools.
0:58:38
Implications of Aducanumab, the New Alzheimer's Drug with Gil Rabinovici and Rita Redberg
0:05:32
Experimental Alzheimer's drug may slow progression, but with significant side effects, study sh...
0:03:31
That Pricey New Alzheimer's Drug? Still Not Great
0:02:59
Expert discusses new Alzheimer's drug
0:03:34
Expert sheds light on new drug to treat Alzheimer's disease
0:02:21
Chicago researchers identify potential new cause of Alzheimer’s disease
0:29:47
The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals
0:07:31
New Study: 29% Improvement In Alzheimer’s Disease?!
0:21:26
Luxembourg Expats Talk Dementia Prevention | Brain Health with PDP Braincoach App | Expat Life Tips
0:05:51
Why is Alzheimer’s disease so difficult to treat? - Krishna Sudhir
0:03:17
The real world impact of the new Alzheimer's drug
0:17:28
Lecanemab: A Potential New Drug For Alzheimer's disease
0:03:01
Potential breakthrough: New treatment for Alzheimer's
0:06:45
US approves first new Alzheimer's drug in 20 years - BBC News
0:02:03
Growing hope over a new Alzheimer's drug, but there are side effects
0:30:43
ALZ Talks: New Advancements in Alzheimer’s Treatments
0:04:50
FDA approves new drug to slow progression of Alzheimer's
0:29:18
The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals
0:02:45
US approves controversial new Alzheimer’s drug
0:04:53
New drug brings hope to end Alzheimer's - BBC News
0:01:39
Impact of Alzheimer's
0:11:30
New Report on Alzheimer's Disease
0:05:01
What The New Alzheimer's Disease Drug Means For Patients
0:24:31
Can a new drug cure Alzheimer's disease? | Inside Story
Комментарии